264 related articles for article (PubMed ID: 10084411)
61. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
Cundy KC
Clin Pharmacokinet; 1999 Feb; 36(2):127-43. PubMed ID: 10092959
[TBL] [Abstract][Full Text] [Related]
62. [Fabrication of cidofovir ampules for intravitreal injections for cytomegalovirus retinitis].
Schleppy CA; Tritten JJ
Rev Med Suisse Romande; 1998 Mar; 118(3):263-5. PubMed ID: 9594603
[No Abstract] [Full Text] [Related]
63. Cytomegalovirus retinitis: new developments in prophylaxis and therapy.
Jacobson MA
AIDS Clin Rev; 1997-1998; ():249-69. PubMed ID: 9305451
[No Abstract] [Full Text] [Related]
64. The changing treatment options for CMV retinitis.
Gilden D
GMHC Treat Issues; 1995; 9(7/8):1-8. PubMed ID: 11362648
[TBL] [Abstract][Full Text] [Related]
65. Cidofovir. Review of current and potential clinical uses.
Safrin S; Cherrington J; Jaffe HS
Adv Exp Med Biol; 1999; 458():111-20. PubMed ID: 10549383
[No Abstract] [Full Text] [Related]
66. CMV retinitis: a clinical management update.
Blanchet KD
AIDS Patient Care STDS; 1996 Apr; 10(2):86-93. PubMed ID: 11361712
[No Abstract] [Full Text] [Related]
67. Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Jacobson MA
N Engl J Med; 1997 Jul; 337(2):105-14. PubMed ID: 9211681
[No Abstract] [Full Text] [Related]
68. Antiviral therapy for cytomegalovirus infections in pediatric patients.
Kimberlin DW
Semin Pediatr Infect Dis; 2002 Jan; 13(1):22-30. PubMed ID: 12118840
[TBL] [Abstract][Full Text] [Related]
69. Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment.
Hammoud Z; Parenti DM; Simon GL
Clin Infect Dis; 1998 May; 26(5):1233. PubMed ID: 9597261
[No Abstract] [Full Text] [Related]
70. Successful treatment of cytomegalovirus encephalitis in an AIDS patient using cidofovir.
Sadler M; Morris-Jones S; Nelson M; Gazzard BG
AIDS; 1997 Aug; 11(10):1293-4. PubMed ID: 9256949
[No Abstract] [Full Text] [Related]
71. Fanconi syndrome associated with cidofovir therapy.
Vittecoq D; Dumitrescu L; Beaufils H; Deray G
Antimicrob Agents Chemother; 1997 Aug; 41(8):1846. PubMed ID: 9257778
[No Abstract] [Full Text] [Related]
72. Cidofovir.
Lea AP; Bryson HM
Drugs; 1996 Aug; 52(2):225-230; discussion 231. PubMed ID: 8841740
[TBL] [Abstract][Full Text] [Related]
73. Vitrectomy and silicone oil tamponade for cidofovir-associated hypotony with ciliary body detachment.
Lin AP; Holland GN; Engstrom RE
Retina; 1999; 19(1):75-6. PubMed ID: 10048378
[No Abstract] [Full Text] [Related]
74. Cidofovir in the treatment of cytomegaloviral disease.
Kendle JB; Fan-Havard P
Ann Pharmacother; 1998 Nov; 32(11):1181-92. PubMed ID: 9825085
[TBL] [Abstract][Full Text] [Related]
75. (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue.
Lalezari JP; Drew WL; Glutzer E; James C; Miner D; Flaherty J; Fisher PE; Cundy K; Hannigan J; Martin JC
J Infect Dis; 1995 Apr; 171(4):788-96. PubMed ID: 7706804
[TBL] [Abstract][Full Text] [Related]
76. Hypotony and visual loss with intravenous cidofovir treatment of cytomegalovirus retinitis.
Friedberg DN
Arch Ophthalmol; 1997 Jun; 115(6):801-2. PubMed ID: 9194736
[No Abstract] [Full Text] [Related]
77. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
Zabawski EJ; Cockerell CJ
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):741-5. PubMed ID: 9810890
[TBL] [Abstract][Full Text] [Related]
78. Saving sight.
Vazquez E
Posit Aware; 1997; 8(6):22-3. PubMed ID: 11364857
[TBL] [Abstract][Full Text] [Related]
79. Cidofovir: new preparation. Of help in CMV retinitis.
Prescrire Int; 1998 Oct; 7(37):135-7. PubMed ID: 10915415
[TBL] [Abstract][Full Text] [Related]
80. Promising new treatments for cytomegalovirus retinitis.
Polis MA; Masur H
JAMA; 1995 May; 273(18):1457-9. PubMed ID: 7723160
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
